Zobrazeno 1 - 10
of 64
pro vyhledávání: '"M B Stenina"'
Autor:
A A Avalyan, E V Oshchepkova, M A Saidova, V N Shitov, E V Glazkova, M B Stenina, I E Chazova
Publikováno v:
Системные гипертензии, Vol 15, Iss 4, Pp 59-64 (2018)
Objective. To study of subclinical cardiotoxicity of two anthracycline-containing chemotherapy regimens in breast cancer patients with normotension and arterial hypertension. Materials and methods. 119 women (mean age 48,8±10,9 years) with triple ne
Externí odkaz:
https://doaj.org/article/464c82ba1b4a42c48ada51931c7bef0e
Autor:
I Ye Chazova, S A Tyulyandin, M V Vitsenia, E P Panchenko, Yu A Fedotkina, M G Poltavskaya, M Yu Gilyarov, T V Martynyuk, A G Ovchinnikov, M B Stenina, O P Trophimova, F T Ageev
Publikováno v:
Системные гипертензии, Vol 15, Iss 1, Pp 6-20 (2018)
Advances in treatment have led to improved survival of patients with cancer but have also resulted in untoward side effects associated with treatment. Cardiovascular diseases are one of the most frequent of these side effects. Myocardial dysfunction
Externí odkaz:
https://doaj.org/article/4e54fc60141c4cd4be0441b1806c447a
Autor:
I Ye Chazova, S A Tyulyandin, M V Vitsenia, A G Ovchinnikov, M G Poltavskaya, M Yu Gilyarov, T V Martynyuk, E P Panchenko, Yu A Fedotkina, M B Stenina, O P Trophimova, F T Ageev
Publikováno v:
Системные гипертензии, Vol 14, Iss 3, Pp 6-20 (2017)
Advances in treatment have led to improved survival of patients with cancer but have also resulted in untoward side effects associated with treatment. Cardiovascular diseases are one of the most frequent of these side effects. Myocardial dysfunction
Externí odkaz:
https://doaj.org/article/0ece9a1172ea4985b491affe3e8ebe55
Autor:
A A Avalyan, M Yu Kirillova, V N Shitov, Ye V Oshchepkova, M A Saidova, M B Stenina, I Ye Chazova
Publikováno v:
Системные гипертензии, Vol 14, Iss 3, Pp 21-27 (2017)
Objective. To study the possibility of the 2D Speckle Tracking Imaging in early detection of cardiotoxicity in patients with triple negative breast cancer and arterial hypertension (AH) during anthracycline-containing chemotherapy. Materials and meth
Externí odkaz:
https://doaj.org/article/00bd6b114a904b0ebb1c56da122870bb
Autor:
M B Stenina
Publikováno v:
Современная онкология, Vol 16, Iss 3, Pp 21-26 (2014)
Anti-HER2 therapy is a standard component of drug therapy for HER2-positive breast cancer. The advent of new drugs of this group creates additional possibilities for treatment and necessitates for creating an algorithm according to the characteristic
Externí odkaz:
https://doaj.org/article/58951dcdd0f64191846ad75571ac3f1e
Autor:
E V Artamonova, V A Gorbunova, N V Zhukov, L V Manzjuk, A G Manihas, P M Paltuev, V F Semiglazov, T Yu Semiglazova, M B Stenina, S A Tjuljandin, V A Chubenko
Publikováno v:
Современная онкология, Vol 16, Iss 2, Pp 12-16 (2014)
The leading oncologists' meeting was held on February 7, 2014 in Moscow. Those in attendance discussed treatment approaches ofbreast cancer, and in particular, locally-advanced and metastatic breast cancer. Participants came to the conclusion that pa
Externí odkaz:
https://doaj.org/article/8d8314f2d766496e8a66aea101011950
Autor:
M A Frolova, M B Stenina
Publikováno v:
Современная онкология, Vol 13, Iss 2, Pp 31-35 (2011)
Externí odkaz:
https://doaj.org/article/f9419f374d784d0c808c28257c44b70c
Publikováno v:
Современная онкология, Vol 12, Iss 4, Pp 30-33 (2010)
Externí odkaz:
https://doaj.org/article/00dbe8b0948846cca903295850324435
Autor:
M B Stenina
Publikováno v:
Современная онкология, Vol 9, Iss 3, Pp 9-12 (2007)
Группа ингибиторов ароматазы (ИА) 3-го поколения включает два обратимых нестероидных ингибитора: летрозол (Фемара) и анастрозол (Аримиде
Externí odkaz:
https://doaj.org/article/0956fdeb0d5e439fbdc91a82141d2bac
Autor:
M B Stenina
Publikováno v:
Современная онкология, Vol 6, Iss 1, Pp 18-24 (2004)
Эпирубицин ( Фарморубицин ) - аналог доксорубицина , является антрациклином , часто используемым при лечении рака молочной железы ( РМЖ ) в
Externí odkaz:
https://doaj.org/article/cda81d08eaed4d2d9216b81d41f5f2cb